Announcement • Feb 27
Eargo Files Form 15 Eargo, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common Stock was $0.0001 per share. Announcement • Feb 20
Eargo, Inc.(NasdaqGS:EAR) dropped from NASDAQ Composite Index Eargo, Inc. has been dropped from NASDAQ Composite Index . Announcement • Jan 31
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings This quarter, Eargo, Inc. launched two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first quarter of 2024). The new devices expand the brand’s portfolio of offerings with a new earbud form factor and a completely-in-canal option focused on Eargo signature essentials. For over a decade, Eargo has set the industry standard for pairing discreet and effortless hearing devices with ongoing expert support. These newest devices address additional consumer needs around functionality, design and experience. Key highlights of each product include: Eargo SE (MSRP $1,650): A streamlined, self-fitting OTC device launching focused on Eargo’s signature essentials – virtually invisible, rechargeable, open-fit, completely-in-canal form factor and lifetime support. With a new ear tip design, companion app, and pocketable charger, Eargo SE pairs quality with simplicity. LINK By Eargo (MSRP $799): A new form factor for the brand launching in the first quarter of 2024, introducing an earbud-style OTC hearing aid that remains true to Eargo’s key hallmarks of discreet design and innovative technology. Going beyond Eargo’s exclusive virtually invisible devices, LINK By Eargo provides users with reliable hearing loss support plus additional capabilities as the first ever low-profile earbud-style hearing device with Bluetooth 5.3 streaming. Eargo’s launch comes at a pivotal time, with growing numbers of people needing hearing support. An estimated 15% of American adults aged 18 and over, or approximately 37.8 million Americans, reported some trouble hearing without a hearing aid, making hearing loss the third most common chronic health condition in the U.S. Even with the number of Americans experiencing noise-induced hearing loss on the rise, people still wait an average of 8.9 years to address their hearing loss due to barriers like cost, lack of awareness and limited access to health services. Hearing aid accessibility has shifted significantly since the FDA created a category for over-the-counter hearing aid devices in 2022. Consumers now have a newly broadened range of alternatives, including more basic devices competing on price over functionality. However, as a result, many new OTC devices still fall short when it comes to challenging the known shortcomings of hearing aid adoption and providing an effortless product and support model that fully benefits the user. Eargo’s portfolio of offerings proves that people with hearing loss don’t need to compromise on quality or a trusted experience when seeking the support they need. Eargo’s complete portfolio of over-the-counter hearing aid devices - including LINK By Eargo, Eargo SE and Eargo 7 - will be available for purchase online. 
